Nutraplus starts production of Lumefantrine at Tarapur plant
Advertisement
New Delhi: Pharma firm Nutraplus India has started commercial production of anti-malarial drug Lumefantrine at its new plant at Tarapur in Maharashtra.
"Previously company was engaged in the manufacturing of intermediate of the same drug... and was selling to various pharma companies," Nutraplus India said in a filing to BSE.
Now, it is manufacturing the final end product at the company's new production facilities, it added.
Saying that this adds to the margins for the company, Nutraplus India said: "This is a forward integration and shall result in better margin."
The company expects to achieve full production capacities in next three months in the plant, it added.
"Previously company was engaged in the manufacturing of intermediate of the same drug... and was selling to various pharma companies," Nutraplus India said in a filing to BSE.
Now, it is manufacturing the final end product at the company's new production facilities, it added.
Saying that this adds to the margins for the company, Nutraplus India said: "This is a forward integration and shall result in better margin."
The company expects to achieve full production capacities in next three months in the plant, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.